{
    "organizations": [],
    "uuid": "2e1fc6520daa6c93b9ea897061be500f461db666",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-paxman-receives-market-approval-in/brief-paxman-receives-market-approval-in-mexico-idUSFWN1RW0J5",
    "ord_in_thread": 0,
    "title": "BRIEF-Paxman Receives Market Approval In Mexico",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - PAXMAN AB (PUBL):\n* PAXMAN RECEIVES MARKET APPROVAL IN MEXICO AND PLANS Q2 LAUNCH WITH LICENSE PARTNER TEVA PHARMACEUTICAL INDUSTRIES LTD\n* RECEIVED MARKET APPROVAL IN MEXICO FOR ITS SCALP COOLING SYSTEM\n* “WE CAN LAUNCH PRODUCT OFFICIALLY ALREADY IN Q2 OF 2018”\n* LICENSE AGREEMENT WITH TEVA WILL GENERATE ONGOING REVENUES BASED ON EVERY COLD CAP OR TREATMENT SOLD Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-19T20:02:00.000+03:00",
    "crawled": "2018-04-20T12:10:55.156+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "paxman",
        "ab",
        "publ",
        "paxman",
        "receives",
        "market",
        "approval",
        "mexico",
        "plan",
        "q2",
        "launch",
        "license",
        "partner",
        "teva",
        "pharmaceutical",
        "industry",
        "ltd",
        "received",
        "market",
        "approval",
        "mexico",
        "scalp",
        "cooling",
        "system",
        "launch",
        "product",
        "officially",
        "already",
        "q2",
        "license",
        "agreement",
        "teva",
        "generate",
        "ongoing",
        "revenue",
        "based",
        "every",
        "cold",
        "cap",
        "treatment",
        "sold",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}